PERSPECTA

News from every angle

← Back to headlines

FDA-Approved Drug Manufacturing Shifts to Europe Amid Tariffs

Due to the impact of tariffs, deals for FDA-approved drug manufacturing are increasingly relocating to Europe, indicating a significant shift in the global pharmaceutical supply chain.

7 Apr, 13:41 — 7 Apr, 13:41
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual14h ago

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

Read full article →

Related Stories

Jeepney Routes Disrupted in Baguio City Amid Fare Confusion

just now

Philippine Senator Warns of Huge Drop in Farmers' Income Due to Surging Fertilizer Prices

just now

BFAR Moves to Regulate Tamban Oversupply in Sorsogon

just now

Philippines Extends Price Freeze on Basic Goods

just now